1 not yet recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
Follow ABP-671 plus febuxostat Group 1: new trials by email Literature Review of ABP-671 plus febuxostat Group 1 trials Research Report on ABP-671 plus febuxostat Group 1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate the Efficacy and Safety of ABP-671 in Subjects With Chronic Kidney Disease and Hyperuricaemia ABP-671 plus febuxostat Group 1, ABP-671 plus febuxostat Group 2, ABP-671 Group - Chronic Kidney Disease | Phase 2 | Not yet recruiting | Atom Therapeutics Co., Ltd | 80 | 2026-06-30 | 2026-06-04 |
Renal Insufficiency, Chronic (1)
Atom Therapeutics Co., Ltd (1)
Australia (1) · China (1)